{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:18:40Z","timestamp":1790605120202,"version":"4.1.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,17]]},"DOI":"10.7759\/cureus.50690","type":"journal-article","created":{"date-parts":[[2023,12,17]],"date-time":"2023-12-17T23:15:25Z","timestamp":1702854925000},"source":"Crossref","is-referenced-by-count":1,"title":["Hepatic Encephalopathy Caused by Long-Term Amiodarone Use"],"prefix":"10.7759","author":[{"given":"Naoki","family":"Murata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinori","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Arioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-020-00401-5","article-title":"Amiodarone: A comprehensive guide for clinicians","volume":"20","author":"Hamilton D Sr","year":"2020","unstructured":"Hamilton D Sr, Nandkeolyar S, Lan H, et al.. Amiodarone: A comprehensive guide for clinicians. Am J Cardiovasc Drugs. 2020, 20:549-58. 10.1007\/s40256-020-00401-5","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2015.08.022","article-title":"Mechanistic review of drug-induced steatohepatitis","volume":"289","author":"Schumacher JD","year":"2015","unstructured":"Schumacher JD, Guo GL. Mechanistic review of drug-induced steatohepatitis. Toxicol Appl Pharmacol. 2015, 289:40-7. 10.1016\/j.taap.2015.08.022","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2478\/jccm-2019-0026","article-title":"Hyperammonemic encephalopathy and lipid dysmetabolism in a critically ill patient after a short course of amiodarone","volume":"5","author":"Cappe M","year":"2019","unstructured":"Cappe M, Hantson P, Komuta M, Vincent MF, Laterre PF, Ould-Nana I. Hyperammonemic encephalopathy and lipid dysmetabolism in a critically ill patient after a short course of amiodarone. J Crit Care Med (Targu Mures). 2019, 5:161-5. 10.2478\/jccm-2019-0026","journal-title":"J Crit Care Med (Targu Mures)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.179.2.2014310","article-title":"Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images","volume":"179","author":"Inoue E","year":"1991","unstructured":"Inoue E, Hori S, Narumi Y, Fujita M, Kuriyama K, Kadota T, Kuroda C. Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images. Radiology. 1991, 179:551-5. 10.1148\/radiology.179.2.2014310","journal-title":"Radiology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20813","article-title":"Genetic variation in the urea cycle: a model resource for investigating key candidate genes for common diseases","volume":"30","author":"Mitchell S","year":"2009","unstructured":"Mitchell S, Ellingson C, Coyne T, et al.. Genetic variation in the urea cycle: a model resource for investigating key candidate genes for common diseases. Hum Mutat. 2009, 30:56-60. 10.1002\/humu.20813","journal-title":"Hum Mutat"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/TACG.S162084","article-title":"Adult-onset type II citrullinemia: current insights and therapy","volume":"11","author":"Hayasaka K","year":"2018","unstructured":"Hayasaka K, Numakura C. Adult-onset type II citrullinemia: current insights and therapy. Appl Clin Genet. 2018, 11:163-70. 10.2147\/TACG.S162084","journal-title":"Appl Clin Genet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-015-1939-3","article-title":"Changing incidence of hyperammonemia in Japan from 2006 to 2013: expansion of new antiepileptic drugs reduces the risk of hyperammonemia","volume":"71","author":"Yamamoto Y","year":"2015","unstructured":"Yamamoto Y, Takahashi Y, Imai K, Mishima N, Kagawa Y, Inoue Y. Changing incidence of hyperammonemia in Japan from 2006 to 2013: expansion of new antiepileptic drugs reduces the risk of hyperammonemia. Eur J Clin Pharmacol. 2015, 71:1517-24. 10.1007\/s00228-015-1939-3","journal-title":"Eur J Clin Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/1755-5922.12258","article-title":"Population-level incidence and monitoring of adverse drug reactions with long-term amiodarone therapy","volume":"35","author":"Rankin S","year":"2017","unstructured":"Rankin S, Elder DH, Ogston S, George J, Lang CC, Choy AM. Population-level incidence and monitoring of adverse drug reactions with long-term amiodarone therapy. Cardiovasc Ther. 2017, 35:10.1111\/1755-5922.12258","journal-title":"Cardiovasc Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.839441","article-title":"Amiodarone-induced multi-systemic toxicity involving the liver, lungs, thyroid, and eyes: a case report","volume":"9","author":"You HS","year":"2022","unstructured":"You HS, Yoon JH, Cho SB, et al.. Amiodarone-induced multi-systemic toxicity involving the liver, lungs, thyroid, and eyes: a case report. Front Cardiovasc Med. 2022, 9:839441. 10.3389\/fcvm.2022.839441","journal-title":"Front Cardiovasc Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000149","article-title":"Acute hepatotoxicity of intravenous amiodarone: case report and review of the literature","volume":"23","author":"Chen CC","year":"2016","unstructured":"Chen CC, Wu CC. Acute hepatotoxicity of intravenous amiodarone: case report and review of the literature. Am J Ther. 2016, 23:e260-3. 10.1097\/MJT.0000000000000149","journal-title":"Am J Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198702193160807","article-title":"Amiodarone","volume":"316","author":"Mason JW","year":"1987","unstructured":"Mason JW. Amiodarone. N Engl J Med. 1987, 316:455-66. 10.1056\/NEJM198702193160807","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/209624-hepatic-encephalopathy-caused-by-long-term-amiodarone-use","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:47Z","timestamp":1707509387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/209624-hepatic-encephalopathy-caused-by-long-term-amiodarone-use"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,17]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.50690","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,17]]}}}